In 2011, Jim Tananbaum established Foresite Capital, a private equity firm focusing on investment in the healthcare industry. The firm provides its clients with working capital, market information and network to help them grow and increase their revenues. After working in the healthcare industry for over 25 years, Jim had amassed a wealth of experience as an entrepreneur and investment expert. His objective was to develop innovative and unique healthcare products that were not exploited by other financial providers at that time. During an interview with Ideamensch, Tananbaum explained how he used published resources on healthcare to understand key investment areas within the industry.
Jim’s typical day is spent with his team members, where they discuss several existing and new portfolios. He also likes spending time with his family, especially when having dinner. Jim prefers to bring ideas to reality by ensuring there is adequate capital and also by engaging the most successful leaders within the healthcare industry. According to the entrepreneur, Foresite Capital’s objective is to support and fund individuals who are lading in finding scientific discoveries that are likely to bring positive effect on the entire industry.
Career Progression of Jim Tananbaum
Currently, Tananbaum on focusing on growing and expanding Foresite Capital’s portfolio and be able to serve more healthcare companies. Before creating Foresite, Jim had partnered with several other entrepreneurs to establish numerous firms. Earlier in his career, Jim co-founded Sierra Ventures, where he was involved in developing a strong foundation for providing healthcare investment services. The entrepreneur was also involved Amerigroup, Amira Pharmaceuticals, Jazz Pharmaceuticals and Health eon. The idea of creating Foresite was to integrate all aspect of his vast experience and develop one investment platform. Visit business profile to know more.
Tananbaum’s Education History
Jim Tananbaum earned his first degree from Yale majoring in math and computer science. He later joined Harvard School of Medicine for his M.D., and then MBA from Harvard Business School. He later joined Massachusetts Institute of Technology for his M.S. He has worked closely with leading scholars and entrepreneurs who have helped him establish himself as a leading investment expert within the healthcare industry.